Is Golden Biotechnology Corporation (4132.TWO) a Buy, Sell, or Hold?
TWO : 4132.TWO
Golden Biotechnology Corporation
$3.47 TWD
$0 (0.0%)
- Volume
- 7.06M
- Average Volume
- 2.78M
- Market Capitalization
- $632.33M
- P/E Ratio
- -1.45
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $36.30
- Year Low
- $3.47
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.92
Company Overview
TWO
Sheng Yong Liu
Drug Manufacturers - Specialty & Generic
Healthcare
4132.TWO
110
TW
TWD
Liquidity Metrics
1.20
0.92
0.75
0.63
0.00
Sales & Valuation
$40.92M
15.45
1.71
-2.38
-1.77
Profitability
-$2.39
-$360.7M
-881.51%
-881.22%
-101.91%
-49.94%
P/E Metrics
-1.45
-0.06
-0.06
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-6.78
1/9
-$132.12M
$546.67M
$356.17M
-$679.39M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Li Yu Wu | President & Director |
| Jun Hua Lian | Treasurer |
| Tai | Chief Scientific Officer |
| Eric Lin | Chief Financial Officer |
| Wenjian Cai | GM & President |
| Sheng Yong Liu | Founder & Chairman of the Board |
Poll Results
No votes yet today — be the first to share your view!
About Golden Biotechnology Corporation (TWO:4132.TWO) Stock
Golden Biotechnology Corporation, founded in 2002 and based in New Taipei City, Taiwan, is engaged in both pharmaceutical drug discovery and the production of health-enhancing dietary supplements. The company operates internationally, serving markets in Taiwan, the United States, Japan, China, Korea, and Singapore. Its varied product line includes several health supplements: Liverty, formulated to support liver function and help alleviate fatigue. Rasle, which serves as an adjunctive therapy for autoimmune conditions. ZSAINO, a nutritional product designed to aid recovery from illness and boost general well-being. UMOOZE, a specialized herbal blend targeting optimal health for men. Furthermore, Golden Biotechnology is developing Antroquinonol, an anticancer molecule. This compound is curre ... ntly utilized in the treatment of severe conditions such as pancreatic cancer, acute myeloid leukemia, and hepatocellular carcinoma, in addition to addressing hypercholesterolemia and hyperlipidemia.
Frequently Asked Questions
-
What is the current Golden Biotechnology Corporation (4132.TWO) stock price?
-
Golden Biotechnology Corporation(TWO:4132.TWO) stock price is $3.47 in the last trading session. During the trading session, 4132.TWO stock reached the peak price of $36.3 while $3.47 was the lowest point it dropped to. The percentage change in 4132.TWO stock occurred in the recent session was 0.0% while the dollar amount for the price change in 4132.TWO stock was $0.
-
4132.TWO's industry and sector of operation?
-
The TWO listed 4132.TWO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of 4132.TWO?
-
Li Yu Wu | President & Director
Jun Hua Lian | Treasurer
Tai | Chief Scientific Officer
Eric Lin | Chief Financial Officer
Wenjian Cai | GM & President -
How many employees does 4132.TWO have?
-
Number of 4132.TWO employees currently stands at 110. 4132.TWO operates from No. 27-6, Zhongzheng E. Road, New Taipei City, None 251, TW.
-
Link for 4132.TWO official website?
-
Official Website of 4132.TWO is: https://www.goldenbiotech.com/en
-
How do I contact 4132.TWO?
-
4132.TWO could be contacted at phone #886 2 2808 6006 and can also be accessed through its website. 4132.TWO operates from No. 27-6, Zhongzheng E. Road, New Taipei City, None 251, TW.
-
How many shares of 4132.TWO are traded daily?
-
The average number of 4132.TWO shares traded daily for last 3 months was 2.78M.
-
What is the market cap of 4132.TWO currently?
-
The market value of 4132.TWO currently stands at $632.33M with its latest stock price at $3.47